Clinical importance of drug-drug interactions
Clinical importance of drug-drug interactions
批准号:
7657356
负责人:
Sean Hennessy
金额:
$47.15万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-15 至 2011-08-31
关键词:
AddressAffectAntibioticsAntifungal AgentsAzolesCase StudyClassificationClinicalConsultationsCrossover DesignDataDatabasesDigoxinDrug InteractionsDrug KineticsDrug Utilization ReviewElderlyEnsureEpidemiologic StudiesFundingFutureGeneral PracticesGlipizideGlyburideKnowledgeMacrolidesMeasuresMedicaidMedical RecordsMedicareOutcomeOutcome MeasureOutcome StudyPatientsPharmaceutical PreparationsPharmacologyProcessPublic HealthQuinolonesRelative RisksResearchResearch PersonnelResourcesRiskSafetySudden DeathSulfonamidesTetracyclinesTextTreatment FactorVentricular ArrhythmiaWarfarinbasecase controlclinical carecomputerized physician order entrydrug standardimprovedinterestknowledge baseprogramsquality improvement organization
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Drug-drug interactions (DDIs) are an important public health problem, especially in the elderly, who are the largest consumers of medications. Nearly all existing knowledge about the clinical importance of potential DDIs comes from pharmacokinetic studies or case reports, both of which have limited utility for identifying clinically important DDIs. As a result, there is a great deal of disagreement among standard DDI reference texts regarding the clinical importance of most potential DDIs. Systematic efforts such as drug utilization review programs and computerized physician order entry that seek to improve medication use depend entirely upon a valid set of clinical rules, and are thus severely hampered by this knowledge gap. To address these critical gaps in existing knowledge of the clinical importance of DDIs, the investigators will perform controlled epidemiologic studies of high-priority potential DDIs that have been selected based on a formal process involving consultation with an Expert Panel of clinicians and clinical pharmacologists. We will use and expand upon an existing, very large pharmacoepidemiologic database consisting of Medicaid data from five large programs, supplemented by Medicare data to ensure complete capture of outcomes in the elderly, together with the General Practice Research Database from the UK. We will examine the validity of our outcome measures using medical record review. Our research strategy will include nested case-control and case-crossover designs, and will yield relative risks, risk differences, and number needed to harm (NNH). Patient and treatment factors associated with developing the adverse outcome of interest will be studied. The results of this study will have important implications for public health, clinical care, and the elucidation of the pharmacology of DDIs, and will serve as a basis for future studies examining factors not recorded in administrative and medical records data.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Drug Interactions Involving Second-generation Antipsychotic Agents Leading to Sudden Cardiac Arrest
-
批准号:10661090
-
项目类别:
-
资助金额:$76.24万
-
财政年份:2022
-
负责人:Sean Hennessy
-
依托单位:
Drug Interactions Involving Second-generation Antipsychotic Agents Leading to Sudden Cardiac Arrest
-
批准号:10501196
-
项目类别:
-
资助金额:$67.99万
-
财政年份:2022
-
负责人:Sean Hennessy
-
依托单位:
Stimulant Overdose in the Medicaid Population: Who is at Risk, and When are They at Risk
-
批准号:10662407
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2021
-
负责人:Sean Hennessy
-
依托单位:
Stimulant Overdose in the Medicaid Population: Who is at Risk, and When are They at Risk
-
批准号:10392130
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2021
-
负责人:Sean Hennessy
-
依托单位:
Drug-Drug Interactions Involving Methadone and Buprenorphine
-
批准号:10436942
-
项目类别:
-
资助金额:$48.37万
-
财政年份:2019
-
负责人:Sean Hennessy
-
依托单位:
Enhancing the Utility of the Trend-in-Trend Research Design
-
批准号:10017817
-
项目类别:
-
资助金额:$54.92万
-
财政年份:2019
-
负责人:Sean Hennessy
-
依托单位:
Drug-Drug Interactions Involving Methadone and Buprenorphine
-
批准号:10205012
-
项目类别:
-
资助金额:$64.75万
-
财政年份:2019
-
负责人:Sean Hennessy
-
依托单位:
Drug-Drug Interactions Involving Methadone and Buprenorphine
-
批准号:10649570
-
项目类别:
-
资助金额:$45.94万
-
财政年份:2019
-
负责人:Sean Hennessy
-
依托单位:
Enhancing the Utility of the Trend-in-Trend Research Design
-
批准号:9813026
-
项目类别:
-
资助金额:$53.11万
-
财政年份:2019
-
负责人:Sean Hennessy
-
依托单位:
Enhancing the Utility of the Trend-in-Trend Research Design
-
批准号:10162467
-
项目类别:
-
资助金额:$56.18万
-
财政年份:2019
-
负责人:Sean Hennessy
-
依托单位:
Drug-Drug Interactions Involving Antidiabetic Agents
-
批准号:9282425
-
项目类别:
-
资助金额:$58.18万
-
财政年份:2014
-
负责人:Sean Hennessy
-
依托单位:
Drug-Drug Interactions Involving Antidiabetic Agents
-
批准号:8891420
-
项目类别:
-
资助金额:$58.92万
-
财政年份:2014
-
负责人:Sean Hennessy
-
依托单位:
Drug-Drug Interactions Involving Antidiabetic Agents
-
批准号:8748916
-
项目类别:
-
资助金额:$63.97万
-
财政年份:2014
-
负责人:Sean Hennessy
-
依托单位:
Ambulatory Care Access and Quality
-
批准号:8578341
-
项目类别:
-
资助金额:$47.66万
-
财政年份:2013
-
负责人:Sean Hennessy
-
依托单位:
Ambulatory Care Access and Quality
-
批准号:9313271
-
项目类别:
-
资助金额:$53.22万
-
财政年份:2013
-
负责人:Sean Hennessy
-
依托单位:
Ambulatory Care Access and Quality
-
批准号:8875037
-
项目类别:
-
资助金额:$52.11万
-
财政年份:2013
-
负责人:Sean Hennessy
-
依托单位:
Staging Activity Limitation
-
批准号:8910589
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2012
-
负责人:Sean Hennessy
-
依托单位:
Staging Activity Limitation
-
批准号:8699622
-
项目类别:
-
资助金额:$30.07万
-
财政年份:2012
-
负责人:Sean Hennessy
-
依托单位:
Staging Activity Limitation
-
批准号:8518208
-
项目类别:
-
资助金额:$29.6万
-
财政年份:2012
-
负责人:Sean Hennessy
-
依托单位:
Data Infrastructure for Post-Marketing Comparative Effectiveness Studies
-
批准号:7819258
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:Sean Hennessy
-
依托单位:
海外基金